Roche buys Singapore facility from Lonza

Global healthcare firm Roche, through its subsidiary Genentech, will acquire a Singapore manufacturing facility from Lonza for up to $360 million.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES